Organization of Regulatory and Clinical Associates
P.O. Box 3490
Redmond, WA 98073
|
Current/Future Events - Event View
This is the "Event Detail" view, showing all available information for this event.
If the event has passed, click the "Event Report" button to read a report and view photos that were uploaded.
Webinar - MDR 2017/45 Implementation Delay Due to Challenges Presented by the COVID 19 Pandemic
The link to the webinar is intended for the registered person ONLY and should not be shared.
All attendees MUST be registered.
This webinar will be recorded.
NEW START TIME is 8:00 AM PST
TOPIC: Main points:
-Remote auditing
-NB designations
-EUDAMED (May 26, 2022)
-Economic Operators: distributors and importers new
requirements (Suppliers)
-PMS
-PMC
-Vigilance
-Risk (EN ISO 14971:2019)
-Class I Medical Devices (grace period)
-EUDAMED (May 26, 2022)
-Certificates renewal
TOPIC DESCRIPTION: EU postponed MDR 2017/45 implementation due to the COVID-19 pandemic. Manufacturers of self-certified, EC marked product under the MDD/MDR as well as EC marked IVD products need to implement MDR new rules by May 26, 2021 instead of May 26, 2020 (As per Regulation 2020/561 amending EU 2017/45).
This allows the placement in the market of medical devices holding valid certificates under the current MDD/IVDD regulatory framework. There will not be a delay for the IVDR implementation scheduled on 26 May 2022.
Guidelines published by regulatory bodies on remote audits support auditing under specific context.
SPEAKER: Lena Huerlimann
SPEAKER BIOGRAPHY: Lena Huerlimann earned a Master of Science in Biology from the University of Zurich, Switzerland. Her thesis was based on an epidemiological study conducted at the Institut fuer Medizinische Mikrobiologie on methicillin-resistant Staphylococcus aureus. She has 23 years of experience in the pharmaceutical and medical device industry. In 2008, she became a full time Lead Auditor for Notified Bodies (NBs). Currently, she works as an independent Lead Auditor and RA Consultant for NBs, Registrars and independent customers. In this role, she helps companies implement, maintain and evaluate conformance of their internal policies and QMS documentation to applicable ISO harmonized standards, local and international regulatory requirement.
WHO: Clinical, regulatory, quality, manufacturing and legal
Attendance at this meeting may be applied as 1.5 points towards RAC re-certification
|